Molecular Biology of Osteosarcoma
Osteosarcoma (OS) is the most frequent primary bone cancer in children and adolescents and the third most frequent in adults. Many inherited germline mutations are responsible for syndromes that predispose to osteosarcomas including Li Fraumeni syndrome, retinoblastoma syndrome, Werner syndrome, Blo...
Main Authors: | Anna M. Czarnecka, Kamil Synoradzki, Wiktoria Firlej, Ewa Bartnik, Pawel Sobczuk, Michal Fiedorowicz, Pawel Grieb, Piotr Rutkowski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/8/2130 |
Similar Items
-
TP53 in Biology and Treatment of Osteosarcoma
by: Kamil Jozef Synoradzki, et al.
Published: (2021-08-01) -
Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma
by: Atik Badshah Shaikh, et al.
Published: (2016-04-01) -
Osteosarcoma Pathogenesis Leads the Way to New Target Treatments
by: Isabel Fernandes, et al.
Published: (2021-01-01) -
Characterization of STAT3 Activation in Osteosarcoma
by: Fossey, Stacey L.
Published: (2010) -
miR-596 suppresses the expression of Survivin and enhances the sensitivity of osteosarcoma cells to the molecular targeting agent anlotinib
by: Wang L, et al.
Published: (2019-08-01)